Mia's Feed
Medical News & Research

Parathyroid Surgery Reduces Diabetes Risk by 30% Through Hormonal Balance Correction

Parathyroid Surgery Reduces Diabetes Risk by 30% Through Hormonal Balance Correction

Share this article

Surgical removal of overactive parathyroid glands may reduce the risk of developing diabetes by 30%, according to new research. Early treatment is crucial for metabolic health benefits.

2 min read

A recent comprehensive study led by researchers from the University of Hong Kong’s School of Clinical Medicine has demonstrated that surgical removal of overactive parathyroid glands, a procedure known as parathyroidectomy, can significantly lower the risk of developing diabetes by approximately 30% in patients diagnosed with primary hyperparathyroidism (PHPT). This condition, characterized by excess calcium in the blood, has long been associated with kidney stones and bone diseases. However, the new findings reveal an important link between PHPT and metabolic health, specifically its potential to impair blood sugar regulation.

The research analyzed electronic health records of more than 3,100 adult patients with PHPT in Hong Kong, tracking their health over a median of almost three years. Results indicated that those who underwent parathyroidectomy exhibited a substantially reduced likelihood of developing diabetes compared to those who did not receive surgery. The study emphasized that this protective effect was more prominent among younger patients and those with severe PHPT.

Surgery appears to offer metabolic benefits beyond its traditional roles in safeguarding renal and bone health. Elevated parathyroid hormone levels, which result from PHPT, may lead to increased calcium within cells, reducing insulin sensitivity and consequently raising blood sugar levels. Correcting this hormonal imbalance through surgery not only addresses calcium regulation but also improves glucose metabolism.

These findings underscore the importance of early diagnosis and treatment of PHPT. Public awareness remains limited despite the condition’s high prevalence—being the third most common endocrine disorder globally—and its potential impact on metabolic health. Healthcare professionals are encouraged to consider surgical options as part of comprehensive management strategies for suitable patients, particularly given the broader benefits for metabolic health and diabetes prevention.

The study, published in JAMA Surgery, reinforces the need for increased vigilance and proactive treatment of PHPT to prevent its wide-ranging health consequences.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Breakthrough Lab Model Links Gene Mutation to Deadly Blood Cancer Progression

A new lab model developed by Birmingham researchers uncovers how a gene mutation accelerates the progression of deadly blood cancer, offering promising avenues for future treatment research.

Michigan's Medicaid Work Requirement System: Lessons and Warnings for Other States

Michigan's Medicaid work requirement system faced legal challenges and implementation hurdles, offering critical lessons for other states considering similar policies amid ongoing debates over healthcare coverage and costs.

Research Uncovers How Gut Microbiota and Genes Worsen Ulcerative Colitis

New research reveals how interactions between gut microbiota and gene mutations, especially in OTUD3, aggravate ulcerative colitis through immune signaling pathways, opening potential for targeted therapies.

Cholesterol Drug Repurposed to Improve Blood-Brain Barrier and Neuropsychiatric Outcomes in DiGeorge Syndrome

Research reveals that cholesterol-lowering drugs may restore mitochondrial function and improve blood-brain barrier integrity, offering new hope for neuropsychiatric conditions in DiGeorge syndrome.